[HTML][HTML] Observational Health Data Sciences and Informatics (OHDSI): opportunities for observational researchers
The vision of creating accessible, reliable clinical evidence by accessing the clinical
experience of hundreds of millions of patients across the globe is a reality. The Observational …
experience of hundreds of millions of patients across the globe is a reality. The Observational …
Characterizing treatment pathways at scale using the OHDSI network
Observational research promises to complement experimental research by providing large,
diverse populations that would be infeasible for an experiment. Observational research can …
diverse populations that would be infeasible for an experiment. Observational research can …
Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysis
Background Uncertainty remains about the optimal monotherapy for hypertension, with current
guidelines recommending any primary agent among the first-line drug classes thiazide or …
guidelines recommending any primary agent among the first-line drug classes thiazide or …
[HTML][HTML] Thirty-day outcomes of children and adolescents with COVID-19: an international experience
…, Y Zhang, AE Williams, CG Reich, G Hripcsak… - …, 2021 - publications.aap.org
OBJECTIVES To characterize the demographics, comorbidities, symptoms, in-hospital
treatments, and health outcomes among children and adolescents diagnosed or hospitalized with …
treatments, and health outcomes among children and adolescents diagnosed or hospitalized with …
Association of hemoglobin A1c levels with use of sulfonylureas, dipeptidyl peptidase 4 inhibitors, and thiazolidinediones in patients with type 2 diabetes treated with …
…, P Jin, M Van Zandt, A Reckard, CG Reich… - JAMA network …, 2018 - jamanetwork.com
Importance Consensus around an efficient second-line treatment option for type 2 diabetes (T2D)
remains ambiguous. The availability of electronic medical records and insurance …
remains ambiguous. The availability of electronic medical records and insurance …
Validation of a common data model for active safety surveillance research
JM Overhage, PB Ryan, CG Reich… - Journal of the …, 2012 - academic.oup.com
Objective Systematic analysis of observational medical databases for active safety surveillance
is hindered by the variation in data models and coding systems. Data analysts often find …
is hindered by the variation in data models and coding systems. Data analysts often find …
Differential effects of chronic unpredictable stress on hippocampal CB1 receptors in male and female rats
CG Reich, ME Taylor, MM McCarthy - Behavioural brain research, 2009 - Elsevier
Chronic unpredictable mild stress (CMS), an animal model of depression, downregulates
hippocampal CB1 receptors in adult male rats. Given that endocannabinoids are implicated in …
hippocampal CB1 receptors in adult male rats. Given that endocannabinoids are implicated in …
Association of ticagrelor vs clopidogrel with net adverse clinical events in patients with acute coronary syndrome undergoing percutaneous coronary intervention
…, D Madigan, G Hripcsak, A Gupta, CG Reich… - Jama, 2020 - jamanetwork.com
Importance Current guidelines recommend ticagrelor as the preferred P2Y12 platelet
inhibitor for patients with acute coronary syndrome (ACS), primarily based on a single large …
inhibitor for patients with acute coronary syndrome (ACS), primarily based on a single large …
Comparative first-line effectiveness and safety of ACE (angiotensin-converting enzyme) inhibitors and angiotensin receptor blockers: a multinational cohort study
…, MJ Schuemie, S Shea, J Duke, N Pratt, CG Reich… - …, 2021 - Am Heart Assoc
ACE (angiotensin-converting enzyme) inhibitors and angiotensin receptor blockers (ARBs)
are equally guideline-recommended first-line treatments for hypertension, yet few head-to-…
are equally guideline-recommended first-line treatments for hypertension, yet few head-to-…
A comparison of the empirical performance of methods for a risk identification system
…, MA Suchard, AG Hartzema, W DuMouchel, CG Reich… - Drug safety, 2013 - Springer
Background Observational healthcare data offer the potential to enable identification of risks
of medical products, and the medical literature is replete with analyses that aim to …
of medical products, and the medical literature is replete with analyses that aim to …